Bleeding Risk of Tirofiban, a Nonpeptide GPIIb/IIIa Platelet Receptor Antagonist in Progressive Stroke: An Open Pilot Study

Publisher： Karger

E-ISSN： 1421-9786|12|4|308-312

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.12, Iss.4, 2001-11, pp. : 308-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates - Receptor binding affinity & specificity

By Mousa S.A.   Bozarth J.   Youssef A.   Levine B.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

Comparison of the Antithrombotic Effects and Bleeding Risk of Fractionated Aurin Tricarboxylic Acid and the GPIIb/IIIa Antagonist GR144053 in a Hamster Model of Stenosis

By Ito T.   Matsuno H.   Kozawa O.   Niwa M.   Sakai N.   Uematsu T.  

Thrombosis Research, Vol. 95, Iss. 1, 1999-07 ,pp. : 49-61

Elsevier

Access to resources Recommend Favorite

Intranasal Antiplatelet/ Antithrombotic Efficacy of a Novel Platelet GPIIB/IIIA Receptor Antagonist DMP755 - a model for in vivo evaluation of antithrombotic agents

By Mousa S.A.   Mu D.-X.   Hussain M.A.  

Thrombosis Research, Vol. 92, Iss. 3, 1998-11 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Platelet GPIIb/IIIa Receptor Antagonists in Human Ischemic Brain Disease

By  

Current Vascular Pharmacology, Vol. 6, Iss. 1, 2008-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

MK-383 (Tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor

By Barlage Stefan   Wimmer Antonia   Pfeiffer Alexandra   Rothe Gregor   Schmitz Gerd  

Platelets, Vol. 13, Iss. 3, 2002-05 ,pp. : 133-140

Informa Healthcare

Access to resources Recommend Favorite